We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

13 hedge funds and large institutions have $93.7M invested in Indaptus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

776% more capital invested

Capital invested by funds: $10.7M → $93.7M (+$83M)

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

117% more funds holding

Funds holding: 6 → 13 (+7)

Holders
13
Holders Change
+7
Holders Change %
+116.67%
% of All Funds
0.32%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$15M
2
ACA
Avoro Capital Advisors
New York
+$14.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$11.1M
4
EC
EcoR1 Capital
California
+$9.66M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$2.28M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$528K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
1
Acuta Capital Partners
California
$24.4M +$15M +1,037 +579%
ACA
2
Avoro Capital Advisors
New York
$19.7M +$14.1M +980 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$15.4M +$11.1M +770 New
EC
4
EcoR1 Capital
California
$13.4M +$9.66M +670 New
CAM
5
Cormorant Asset Management
Massachusetts
$7.25M – – –
MIFH
6
Migdal Insurance & Financial Holdings
Israel
$4.67M – – –
SAM
7
Sectoral Asset Management
Quebec, Canada
$3.18M +$2.28M +158 New
NC
8
Nexthera Capital
New York
$2.47M +$1.77M +123 New
PVI
9
Pura Vida Investments
New York
$895K +$649K +45 New
Renaissance Technologies
10
Renaissance Technologies
New York
$720K +$346K +24 +200%
CC
11
Caxton Corporation
New Jersey
$681K +$490K +34 New
Deutsche Bank
12
Deutsche Bank
Germany
$647K +$303K +21 +191%
UBS Group
13
UBS Group
Switzerland
$289K +$202K +14 New
Bank of America
14
Bank of America
North Carolina
$6K – – –
Morgan Stanley
15
Morgan Stanley
New York
$4K – – –
IA
16
IFP Advisors
Florida
$1K – – –
SM
17
Sabby Management
Florida
– -$528K -41 Closed

INDP Hedge Fund Activity: Q3 2017 in Review

13 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q3 2017, worth a combined $93.7M — up 776% from $10.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new INDP positions and 1 closed out — a net gain of 7 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $15M. The largest seller was Sabby Management, exiting entirely with an estimated $528K sold.

  • 13 institutional investors held Indaptus Therapeutics (INDP) as of Q3 2017, up from 6 in Q2 2017.
  • Funds reported $93.7M of Indaptus Therapeutics stock for Q3 2017, up 776% quarter-over-quarter.
  • 8 funds opened new Indaptus Therapeutics positions in Q3 2017 and 1 closed out, a net change of +7 holders.
  • The largest Indaptus Therapeutics buyer in Q3 2017 was Acuta Capital Partners, an estimated $15M added.
  • The largest Indaptus Therapeutics seller in Q3 2017 was Sabby Management, an estimated $528K sold.

Based on aggregated 13F filings for Q3 2017.